Objective: Vitamin D has been linked to antimüllerian hormone levels, suggesting a possible association with greater ovarian reserve, but large population-based studies are lacking. Our objective was to explore the association between vitamin D and follicle-stimulating hormone (FSH) in premenopausal women.
V itamin D is known for its role in bone health, 1 but its role in reproduction is an active area of investigation. 2<4 Vitamin D receptors are expressed in the ovary, placenta, and uterus. 2<4 Lower vitamin D levels have been related to premenstrual syndrome, uterine fibroids, 5 dysmenorrhea, and early menarche. 4 Diet-induced vitamin D deficiency has been associated with dramatically reduced fertility in both rats and mice. 2, 6 Female knockout mice with no functional vitamin D receptors showed hypergonadotropic hypogonadism, a condition characterized by high levels of follicle-stimulating hormone (FSH) and low levels of estrogen. Low levels of 25-hydroxyvitamin D (25(OH)D) have also been associated with primary ovarian insufficiency in humans. 7 Data from prostate cancer cells
show that the antimüllerian hormone (AMH) promoter region contains a vitamin D response element. 8 Given these studies, we hypothesized that vitamin D may be important for maintaining the health of primordial follicles or for limiting excess recruitment from the primordial follicle pool and, thus, depletion of ovarian reserve. Early follicularphase FSH, which can be measured in blood or urine, is a biomarker of ovarian reserve that rises across the late reproductive life span and is inversely related to AMH. 9 We theorized that vitamin D, measured as plasma 25(OH)D, would be inversely correlated with FSH in late-reproductive-age women.
METHODS

Study sample
The National Institute of Environmental Health Sciences Uterine Fibroid Study (1996-1999) enrolled participants identified from a large health plan in Washington, DC. 5, 10, 11 In brief, randomly selected health plan members aged between 30 and 49 years were contacted, and 80% of those eligible participated (N = 1,430). For this analysis, only women who were premenopausal and not currently using oral contraceptives were included (N = 1,148; Fig. 1 ). Women were invited to the primary care site for an in-person study visit that included a blood draw. Blood samples were processed and stored at j80-C.
Vitamin D measurement
Vitamin D status was ascertained through measurement of the circulating metabolite 25(OH)D in stored plasma samples. 25(OH)D is a widely accepted biomarker for vitamin D. 12 25(OH)D was measured by radioimmunoassay 13 in a laboratory that has been certified by the international Vitamin D External Quality Assessment Scheme for the past 12 years (intra-assay and interassay coefficients of variation were 7.6% and 10.6%, respectively 5 ). The antibody was cospecific for both 25(OH)D 2 and 25(OH)D 3 . One hundred fifty-five women were missing a 25(OH)D measurement; most of them had no available blood sample. This left 993 women available for analysis of vitamin D.
FSH measurement
We measured FSH in urine. Urinary FSH is highly correlated with serum FSH (r = 0.9, P G 0.01 14 ) , and it is much easier to obtain urine samples timed to the menstrual cycle than timed blood samples because women can collect their own urine at home. The first approximately 600 premenopausal women enrolled in the study were asked to collect two consecutive first-morning-urine samples starting on days 1, 2 or 3 of the menstrual cycle. Samples were refrigerated and shipped overnight in a cold storage kit with freezer packs (provided by the study) to the study site in North Carolina. Upon arrival, equal aliquots from each day were pooled. Women who were not asked to collect menstrually timed urine samples instead collected a first-morning-urine sample on the day of their study clinic visit. Women who attended the clinic visit without bringing a first-morning-urine sample were asked to provide a spot sample. Glycerol was added to all urine samples, which were stored at j80-C. Menstrual cycle day was reported at the clinic visit and in menstrual diary data collected during the menstrual cycle after the visit.
Urinary FSH (mIU/mg creatinine) was measured in duplicate using a noncompetitive time-resolved immunofluorometric assay. 15 Creatinine was measured spectrophotometrically. Within-assay and between-assay percent coefficients of variation were 3.1% and 1.1% for FSH and 2.2% and 4.2% for creatinine. To avoid the midcycle peak of FSH, we used FSH information for women whose urine sample was collected during the first 5 days of the menstrual cycle or 5 days before the onset of subsequent menses (n = 527; Fig. 1 ). Of these 527 women, 436 women used the urine collection kit starting on day 1, 2, or 3 of the menstrual cycle to collect two first-morningurine samples that were subsequently pooled. Of the remaining women, single first-morning-urine specimens were provided by 73 women, whereas 16 women provided a spot urine sample at their study visit. Before statistical analysis, creatinine-adjusted FSH was log-transformed to achieve normality.
Covariates
Data on covariates were collected through a self-administered questionnaire and a telephone interview. Body weight was measured at the clinic visit. Potential confounders considered included the following: age, education, race, body mass index, alcohol intake, cigarette smoking, physical activity, age at menarche, gravidity, mother's age at menopause, menstrual cycle day of urine collection, and season of blood draw (winter vs other).
Statistical analysis
The association between 25(OH)D and the natural logarithm of FSH was analyzed through multivariable linear regression. Regression coefficients from this model were first multiplied by 10 (corresponding to a 10-ng/mL increase in 25(OH)D), exponentiated, and multiplied by 100; they are presented as percent change in FSH.
FSH analysis was initially adjusted for only age, race, and cycle day of urine collection (Bmodel 1[). A second fully adjusted model, Bmodel 2,[ included the previous variables and body mass index, current smoking, and season of blood draw. Adjustment for education, alcohol intake, gravidity, and mother's age at menopause did not alter the results and was excluded from the final model. Sensitivity analyses were performed to compare the association between women who collected urine only on days 1, 2 or 3 of the menstrual cycle (n = 436) and the sample as a whole (n = 527; Fig. 1 ). Of the 527 women in the complete sample, 7 women reported having had one ovary removed (one woman was missing this information) and 11 self-reported a diagnosis of polycystic ovary syndrome. On sensitivity analysis, results were unchanged after these women were excluded.
RESULTS
Participants were aged between 35 and 51 years at the time of blood draw (mean/median age, 42 y; Table 1 ). Most women were black, a little more than half had at least a college degree, and almost 80% had been pregnant at least once. Approximately 60% of the women were overweight or obese, about 80% of the women were nonsmokers, and about half of the women drank no more than one drink per week, on average. In model 1, there was a highly significant inverse association between 25(OH)D and FSH levels, with a 10-ng/mL decrease in 25(OH)D being associated with an approximately 10% increase in FSH (Table 2, Fig. 3 ). Adjustment for all covariates increased the estimate to 14% (Table 2 ). Limiting the sample to women who collected pooled urine samples starting on days 1, 2 or 3 of the menstrual cycle did not substantially alter these associations (Table 2 ). Excluding women with diabetes (n = 17) also did not alter these associations (data not shown). The adjusted association was slightly stronger for women younger than 40 years (percent change, j19%; 95% CI, j33 to j6; P = 0.007) than for women aged at least 40 years (percent change, j12%; 95% CI, j24 to j0.1; P = 0.05). Ninety percent of black women had a 25(OH)D level below 20 ng/mL compared with 50% of white women. The adjusted association of 25(OH)D and FSH was stronger among black women (percent change, j18%; 95% CI, j31 to j4; P = 0.01) than among white women (percent change, j9%; 95% CI, j23 to 4; P = 0.18), although a test of the multiplicative interaction term between race and 25(OH)D in the model was not significant (P = 0.30).
DISCUSSION
Lower plasma 25(OH)D levels were associated with higher FSH levels, a biomarker of ovarian reserve that suggests a decrease in primordial follicles and a possible acceleration toward menopause. Previous studies examining the relationship between vitamin D and ovarian reserve have measured AMH levels. AMH, which is produced by the granulosa cells of preantral and early antral follicles, seems to be an important regulator of follicle development. 16 Serum levels of AMH have also been shown to be an indicator of ovarian reserve. 9, 17 Human studies have reported a positive correlation between serum 25(OH)D and AMH. 18, 19 One of these studies involved a unique cohort of women participating in a human immunodeficiency virus infection study and reported that the association was limited to women older than 40 years. 19 The other publication described an intervention study in New Zealand that included only 33 women. 18 Dennis et al 18 reported that AMH varied across seasons and that supplementation with cholecalciferol (vitamin D 3 ) prevented seasonal AMH changes. This would suggest that vitamin D may affect the preantral or antral follicle pool, which can fluctuate in size, but not the primordial follicles. Age at menopause has been associated with sun exposure in two studies of Turkish populations 20, 21 and in a study of Italian nuns. 22 In all three studies, women whose lifelong sun exposure was estimated to be low (caused by sun avoidance, covered dressing, or lack of outdoor activity) had an earlier age at menopause. It is possible that vitamin D is a mechanism underlying this association.
The ability to produce vitamin D in the skin is dependent on skin pigmentation, 23 and pigmentation varies with race/ ethnicity. In the United States, vitamin D levels are correspondingly lower among African Americans than among nonHispanic whites. 24 However, ethnic groups differ on many factors, and data on age at menopause and race/ethnicity are mixed.
25<30
The mechanism by which vitamin D may affect ovarian reserve is unknown. Ovarian reserve is susceptible to toxicants such as tobacco smoke. 31 Smoking effect on ovarian reserve seems to be most evident during the perimenopausal years, as evidenced by the fact that only current smoking during the late reproductive years and perimenopause seems to affect age at menopause. 32, 33 In contrast, the current study found that the inverse relationship between FSH and vitamin D seemed to be somewhat stronger in younger participants. This suggests the possibility that long-term low vitamin D levels might have a more continuous adverse effect on ovarian reserve.
This analysis incorporates a population-based sample and a larger sample size (n = 527) compared with the two previous AMH studies (n = 388 and n = 33). This study is also strengthened by its use of a plasma 25(OH)D measurement performed by a well-recognized expert and developer of the assay. 12 The laboratory has participated in and has been certified by the Vitamin D External Quality Assessment Scheme survey for the past 12 years. The intra-assay and interassay variations are less than 10% based on laboratory controls. Most of the women in this study had inadequate 25(OH)D levels based on the Institute of Medicine standard. This improves the power of the study to detect an association between low vitamin D and FSH, although it may also limit the generalizability of our results to more vitamin DYreplete populations. Similarly, most of this population was black and older than 35 years, which limits generalizability to women of other races and younger women. This study included a thorough collection of menstrual cycle information, which minimizes misclassification of the FSH measure. FSH was measured in urine rather than in blood, which may limit its clinical interpretation. However, the correlation between blood and urine measurements is high.
14 AMH was not measured in this population; thus, we were unable to assess the association between 25(OH)D and AMH. Although all women in our analysis reported being premenopausal, some of them may have been perimenopausal, and levels of both 25(OH)D and FSH may change during menopause. However, when we limited our analysis to women younger than 40 years, the association between 25(OH)D and FSH was stronger, suggesting minimal influence of perimenopause on our results.
CONCLUSIONS
Vitamin D is inversely related to urinary FSH levels in a population of older premenopausal women. This suggests that vitamin D may influence ovarian reserve and, as such, may have implications for fecundability in older women. The mechanism through which vitamin D may affect FSH is unknown and warrants further investigation. 
